. Contraction-induced increase in V max of palmitate uptake and oxidation in perfused skeletal muscle. J. Appl. Physiol. 84(5): 1788-1794, 1998.-To evaluate the effects of contractions on the kinetics of uptake and oxidation of palmitate in a physiological muscle preparation, rat hindquarters were perfused with glucose (6 mmol/l), albuminbound [1-14 C]palmitate, and varying amounts of albuminbound palmitate (200-2,200 µmol/l) at rest and during muscle contractions. When plotted against the unbound palmitate concentration, palmitate uptake and oxidation displayed simple Michaelis-Menten kinetics with estimated maximal velocity (V max ) and Michaelis-Menten constant (K m ) values of 42.8 Ϯ 3.8 (SE) nmol · min Ϫ1 ·g Ϫ1 and 13.4 Ϯ 3.4 nmol/l for palmitate uptake and 3.8 Ϯ 0.4 nmol · min Ϫ1 ·g Ϫ1 and 8.1 Ϯ 2.9 nmol/l for palmitate oxidation, respectively, at rest. Whereas muscle contractions increased the V max for both palmitate uptake and oxidation to 91.6 Ϯ 10.1 and 16.5 Ϯ 2.3 nmol · min Ϫ1 ·g Ϫ1 , respectively, the K m remained unchanged. V max and K m estimates obtained from Hanes-Woolf plots (substrate concentration/velocity vs. substrate concentration) were not significantly different. In the resting perfused hindquarter, an increase in palmitate delivery from 31.9 Ϯ 0.9 to 48.7 Ϯ 1.2 µmol · g Ϫ1 ·h Ϫ1 by increasing perfusate flow was associated with a decrease in the fractional uptake of palmitate so that the rates of uptake and oxidation of palmitate remained unchanged. It is concluded that the rates of uptake and oxidation of long-chain fatty acids (LCFA) saturate with an increase in the concentration of unbound LCFA in perfused skeletal muscle and that muscle contractions, but not an increase in plasma flow, increase the V max for LCFA uptake and oxidation. The data are consistent with the notion that uptake of LCFA in muscle may be mediated in part by a transport system. electrical stimulation; fatty acid metabolism; fatty acid transport; fatty acid uptake; hindquarter perfusion; skeletal muscle CIRCULATING ALBUMIN-BOUND fatty acids are a major oxidizable fuel source for skeletal muscle metabolism. The metabolism of albumin-bound ligands, such as long-chain fatty acids, is a complex process that involves many steps, one of which is the permeation of free fatty acids (FFA) across the cell membranes and interstitium. Because of their lipid nature, FFA flux across plasma membranes has long been considered a passive diffusional process. This notion was reinforced by the existence of a linear relationship between total plasma FFA concentration and FFA utilization in humans and dogs at rest and during exercise (4, 13). However, Ͼ99% of the FFA carried in plasma are bound to albumin, and, according to the conventional theory of cellular uptake for protein-bound ligand, only unbound ligand participates in the uptake process (5). Within the past decade, experimental evidence has emerged to show that FFA uptake across the plasma membranes of cells with high FFA fluxes is indeed dependent on the concentration of unbound plasma FFA and that the initial uptake rate of FFA saturates with an increase in the unbound plasma FFA concentration (2, 3, 15, 19, 22, 24) . In perfused rat skeletal muscle at rest, we have shown that the uptake of palmitate saturates with an increase in unbound perfusate plasma palmitate concentration (27). The existence of a saturable relationship between the cellular uptake of plasma FFA and the concentration of unbound plasma FFA suggests that FFA uptake across plasma membranes of muscle cells may also be mediated in part by a facilitated transport system (15).
CIRCULATING ALBUMIN-BOUND fatty acids are a major oxidizable fuel source for skeletal muscle metabolism. The metabolism of albumin-bound ligands, such as long-chain fatty acids, is a complex process that involves many steps, one of which is the permeation of free fatty acids (FFA) across the cell membranes and interstitium. Because of their lipid nature, FFA flux across plasma membranes has long been considered a passive diffusional process. This notion was reinforced by the existence of a linear relationship between total plasma FFA concentration and FFA utilization in humans and dogs at rest and during exercise (4, 13) . However, Ͼ99% of the FFA carried in plasma are bound to albumin, and, according to the conventional theory of cellular uptake for protein-bound ligand, only unbound ligand participates in the uptake process (5) . Within the past decade, experimental evidence has emerged to show that FFA uptake across the plasma membranes of cells with high FFA fluxes is indeed dependent on the concentration of unbound plasma FFA and that the initial uptake rate of FFA saturates with an increase in the unbound plasma FFA concentration (2, 3, 15, 19, 22, 24) . In perfused rat skeletal muscle at rest, we have shown that the uptake of palmitate saturates with an increase in unbound perfusate plasma palmitate concentration (27) . The existence of a saturable relationship between the cellular uptake of plasma FFA and the concentration of unbound plasma FFA suggests that FFA uptake across plasma membranes of muscle cells may also be mediated in part by a facilitated transport system (15) .
At a given plasma FFA concentration, the rate of FFA utilization is dependent on the metabolic rate (7, 10) . In humans, muscle contractions have been shown to increase plasma FFA uptake and utilization at a specific plasma FFA concentration (7, 10, 14, 28) . In perfused rat hindquarters, plasma palmitate uptake at a plasma palmitate concentration of 2,000 µmol/l was found to be 55% higher in contracting skeletal muscles compared with muscles at rest (26) . However, it is not known whether during muscle contractions plasma FFA uptake and oxidation would still follow saturation kinetics and, if so, whether the increases in plasma FFA uptake and oxidation would be associated with an increase in maximal velocity (V max ) or a decrease in Michaelis-Menten constant (K m ) or both.
Therefore, the purpose of this study was to determine the kinetics of the uptake and oxidation of plasma palmitate in the perfused isolated rat hindquarter at rest and during electrically induced muscle contractions. The perfused rat hindquarter was used to provide an intact physiological in vitro muscle preparation.
MATERIALS AND METHODS
Animal preparation. Male Wistar rats were housed in pairs, maintained on a 12:12-h light-dark cycle, and received regular rat chow and water ad libitum. On the day of the experiment, fed rats weighing between 250 and 300 g were anesthetized with pentobarbital sodium (5 mg/100 g body wt ip) and prepared surgically for hindquarter perfusion as previously described (18) . Before insertion of the perfusion catheters, heparin (150 IU) was administered into the inferior vena cava. The rats were killed with an intracardial injection of pentobarbital sodium immediately before the catheters were inserted, and the preparation was placed in a perfusion apparatus, essentially as described by Ruderman et al. (18) . The first 25 ml of perfusate that passed through the hindquarter were discarded, whereupon the perfusate was recirculated at a flow of 12.5 ml/min (0.58 ml · min Ϫ1 ·g Ϫ1 perfused muscle). After an equilibration period of 20 min, the left illiac vessels were tied off, and a clamp was fixed tightly around the proximal part of the leg. The right leg was then perfused at rest for 20 min at a prefusate flow of 9 ml/min (0.42 ml · min Ϫ1 ·g Ϫ1 ). Resting arterial and venous perfusate samples were taken at 10, 15, and 20 min. After perfusion at rest, the right leg was quickly immobilized at the tibiopatellar ligament, and a hook electrode was placed around the sciatic nerve and connected to a Disa stimulator (Disa Electronic, Herlev, Denmark). Perfusate flow was increased to 15 ml/min (0.71 ml · min Ϫ1 ·g Ϫ1 ). The resting length of the gastrocnemiussoleus-plantaris muscle group was adjusted to obtain maximum active tension on stimulation. Isometric contractions were induced by stimulating the sciatic nerve electrically with supramaximal (10-20 V) trains of 100 ms and 100 Hz, with an impulse duration of 1 ms and delivery every 3 s. During muscle stimulation, the tension developed by the gastrocnemius-soleus-plantaris muscle group was recorded on a Clevite brush recorder. The decrease in tension development over the stimulation period was used as an indicator of performance. Arterial and venous perfusate samples were taken after 5, 10, 15, 20, and 25 min of electrical stimulation. Arterial and venous perfusate samples for the analysis of [ 14 C]FFA and 14 CO 2 radioactivities were taken after 10, 15, and 20 min of perfusion at rest and after 15, 20, and 25 min of perfusion during electrical stimulation. Arterial and venous perfusate samples for PCO 2 , PO 2 , pH, and hemoglobin determinations were taken after 15-20 min of equilibration at rest and during electrical stimulation. The exact muscle mass perfused was determined by infusing a colored solution of methyl blue into the arterial catheter and weighing the colored muscle mass at the end of the perfusions.
Additional experiments were conducted to determine the effects of perfusate flow rate on palmitate metabolism at rest. Thus, in a subsample of rats (n ϭ 8), unilateral perfusion of the resting hindquarter was performed at a flow rate of 9 ml/min (0.42 ml · min Ϫ1 ·g Ϫ1 ) for 20 min, after which time the flow rate was increased to 15 ml/min (0.71 ml · min Ϫ1 ·g Ϫ1 ) for another 20 min. The experimental procedures were the same as described above, except that all rats were perfused with high concentrations of albumin-bound palmitate (1,450-2,010 µmol/l).
Blood and muscle sample analyses. Arterial and venous perfusate samples were analyzed for glucose, lactate, and FFA concentrations as well as for [ 14 C]FFA and 14 CO 2 radioactivities. Samples for glucose and lactate were kept on ice and analyzed by using YSI 23 glucose and lactate analyzers (Yellow Springs Instruments, Yellow Springs, OH) within 30 min of collection. Samples for FFA were put in 200 µmol/l of EGTA (pH 7) and centrifuged, and the supernatant was frozen until analyzed fluorometrically (14) . Because the FFA concentration was low in the absence of added palmitate (Ͻ90 µmol/l) and because palmitate was the only fatty acid added, measured FFA concentrations were taken to equal palmitate concentrations.
To determine plasma palmitate radioactivity, duplicate 100-µl aliquots of the perfusate plasma were mixed with liquid scintillation fluid (Maxifluor, J. T. Baker, Devente, Holland) and counted in a Packard liquid scintillation counter (model 2000 CA, Packard Instruments, Downers Grove, IL). To ascertain that the radioactivity in the plasma was due solely to FFA, lipid extraction and separation were performed on a subsample (n ϭ 5) of perfusate samples as previously described (25, 28) . The recovered palmitate fraction contained 98% of the total radioactivity on the plate, and that amount corresponded to Ͼ92% of the total radioactivity present in the plasma samples. Thus total plasma radioactivity was used to calculate the specific activity of palmitate in the perfusate. The liberation and collection of 14 CO 2 from the blood were performed within 4-5 min of anaerobic collection (2 ml) as previously described (25, 28) . In this system, arterial perfusate plasma palmitate concentration and specific activity as well as the arteriovenous difference in radioactivity varied by Ͻ5% during the last 20 min of perfusion at rest and during the last 15 min of perfusion during electrically induced muscle contractions (25, 26) . Thus steady-state conditions were achieved. Perfusate samples for the determination of PCO 2 , PO 2 , pH, and hemoglobin were collected anaerobically, placed on ice, and measured within 15 min of collection with an ABL 30 acid-base laboratory and an OSM2 hemoximeter, respectively (Radiometer, Copenhagen, Denmark).
Calculations and statistics. The equilibrium concentration of unbound palmitate was calculated by the stepwise equilibrium constant method (31) by using the dissociation constants for the palmitate-albumin complex reported by both Spector et al. (23) and Richieri et al. (16) . The fractional uptake was calculated as the difference in radioactivity between the arterial and venous perfusate samples divided by the radioactivity in the arterial sample (7). Palmitate delivery was calculated by multiplying perfusate plasma flow by the arterial perfusate plasma palmitate concentration. Palmitate uptake was calculated by multiplying plasma delivery by the fractional uptake (7). Percent palmitate oxidation was calculated by dividing the total amount of radioactivity recovered as 14 CO 2 by the total amount of radioactivity that was taken up by the muscles (11) . Total palmitate oxidation was calculated by multiplying palmitate uptake by the percent oxidation. Glucose and oxygen uptake as well as lactate release across the hindquarter were calculated by multiplying perfusate flow by the arteriovenous difference in concentration and were expressed per gram of perfused muscle, which was measured to be 7.8 Ϯ 0.4% of body weight for unilateral hindquarter perfusion.
The arterial and venous specific activities for palmitate were 2.55 Ϯ 0.11 and 2.42 Ϯ 0.1 µCi/µmol at rest, respectively (P Ͼ 0.05) and did not vary over time (P Ͼ 0.05). Because the calculated rates of palmitate uptake and oxidation did not change significantly during the last 15 min of perfusion at rest and electrical stimulation, the average of the values was used in the kinetic curves for palmitate uptake and oxidation. The data were fitted to a rectangular hyperbolic function, and V max and K m values for the uptake and oxidation of palmitate were estimated by using the PRISM computer program (GraphPad, San Diego, CA) at rest and during electrical stimulation. V max and K m values for the uptake and oxidation of palmitate were also estimated and compared from Hanes and V is velocity), the best-fit data points of which were obtained by using linear regression analysis. With these plots, the slope is equal to 1/V max , the y-intercept to K m /V max and, the x-intercept to ϪK m . Variance estimation was done by using the Delta method (6) . Differences between the estimates obtained by the two methods of calculation were evaluated by calculating the F-ratio. A one-way analysis of variance with repeated measures was used to test for differences due to changes in perfusion flow rates. In all instances, an ␣ of 0.05 was used to determine statistical significance.
RESULTS
Palmitate metabolism. When plotted as a function of the unbound perfusate plasma palmitate concentration, calculated by using the association constants of Richieri et al. (16) , the rates of palmitate uptake and palmitate oxidation displayed saturation kinetics and could be fitted to a Michaelis-Menten relationship both at rest and during electrical stimulation (Fig. 1) . Analysis of the data yielded V max and K m estimates of 42.8 Ϯ 3.8 nmol · min Ϫ1 ·g Ϫ1 and 13.4 Ϯ 3.4 nmol/l for palmitate uptake and of 3.8 Ϯ 0.4 nmol · min Ϫ1 ·g Ϫ1 and 8.1 Ϯ 2.9 nmol/l for palmitate oxidation, respectively, at rest. The V max for palmitate uptake and oxidation increased significantly during electrical stimulation to reach values of 91.6 Ϯ 10.1 and 16.5 Ϯ 2.3 nmol · min Ϫ1 ·g Ϫ1 , respectively. The K m values for palmitate uptake and oxidation were unchanged by electrical stimulation.
Hanes-Woolf plots, [S]/v vs. [S]
, generated straight lines with the slope equal to 1/V max , the x-intercept equal to ϪK m , and the y-intercept equal to K m /V max (Fig.  2) . The Hanes-Woolf plots for both palmitate uptake and oxidation demonstrated significantly different slopes between rest and electrical stimulation, whereas the x-intercepts remained unchanged. Thus, by both methods of estimation, electrical stimulation significantly increased the V max for both palmitate uptake (110-115%) and oxidation (330-390%) but did not change the K m value. When plotted as a function of the total plasma palmitate concentration, the rates of palmitate uptake and oxidation displayed straight-line relationships (Fig. 3) . Electrical stimulation was associated with an increase in the slopes of the lines.
When plotted as a function of the unbound perfusate plasma palmitate concentration, calculated by using the association constants provided by Spector et al. (23) , the rates of palmitate uptake and oxidation also displayed saturation kinetics. Although the calculated V max values were slightly lower (33.3 Ϯ 1.7 and 3.2 Ϯ 0.2 nmol · min Ϫ1 ·g Ϫ1 for palmitate uptake and oxidation at rest, respectively) than those calculated with the constants of Richieri et al. (16) , the contraction-induced increase in V max was of a similar magnitude (96 and 260% for palmitate uptake and oxidation, respectively). The K m values were higher than those calculated by using the constants provided by Richieri et al. However, as observed above, the K m estimates for palmitate uptake and oxidation were unchanged by electrical stimulation. Thus, as observed above with the constants of Richieri et al., muscle contractions were associated with an increase in V max but no change in K m .
Resting arterial perfusate glucose concentration averaged 6.2 Ϯ 0.1 mmol/l and decreased by 9.6% during electrical stimulation to reach a value of 5.6 Ϯ 0.2 mmol/l (P Ͻ 0.05). Glucose uptake was stable at rest and averaged 4.6 Ϯ 0.5 µmol · g Ϫ1 ·h Ϫ1 . Glucose uptake increased significantly during electrical stimulation and reached an average value of 27.4 Ϯ 3.5 µmol·g Ϫ1 ·h Ϫ1 during the last 15 min of the stimulation period. Resting arterial perfusate lactate concentration averaged 0.9 Ϯ 0.05 mmol/l and increased by 65% during electrical stimulation to reach a value of 2.6 Ϯ 0.1 mmol/l. Lactate release was stable at rest and averaged 4.9 Ϯ 0.7 µmol · g Ϫ1 ·h Ϫ1 . Lactate release was highest after 5 min of electrical stimulation and decreased thereafter to reach an average value of 59.2 Ϯ 6.1 µmol · g Ϫ1 ·h Ϫ1 at the end of the stimulation period. Resting oxygen uptake was stable and averaged 35.7 Ϯ 3.1 µmol · g Ϫ1 ·h Ϫ1 . Oxygen uptake was more than twice as high during electrical stimulation and reached an average value of 82.0 Ϯ 4.3 µmol · g Ϫ1 ·h Ϫ1 . The initial amount of tension developed by the contracting muscles averaged 1,686 Ϯ 162 g. Muscle tension development decreased markedly during the first few minutes of electrical stimulation, followed by a more gradual decrease. By the end of the stimulation period, muscle tension development had decreased by 63.9 Ϯ 3.6%.
Effect of flow rate on palmitate metabolism. To evaluate the effect of flow rate on palmitate metabolism, perfusate flow rate was increased from 9 to 15 ml/min during unilateral perfusion of the resting hindquarter at high perfusate plasma palmitate concentration (Table 1) . Perfusate plasma palmitate concentration was similar in both groups and averaged 1,712 Ϯ 57 µmol/l. The increase in perfusate flow rate from 9 to 15 ml/min was associated with a 53% increase in the rate of plasma palmitate delivery to the hindquarter and a 37% decrease in the fractional uptake rate of palmitate. [S], showing saturation kinetics of palmitate uptake (B) and oxidation (A) in perfused rat hindquarters at rest (y ϭ 0.02x ϩ 0.34, r 2 ϭ 0.85 for palmitate uptake and y ϭ 0.27x ϩ 2.45, r 2 ϭ 0.73 for palmitate oxidation) and during electrical stimulation (y ϭ 0.01x ϩ 0.29, r 2 ϭ 0.81 for palmitate uptake and y ϭ 0.05x ϩ 1.81, r 2 ϭ 0.68, for palmitate oxidation). Slope is 1/V max , y-intercept is K m /V max , and x-intercept is ϪK m , where V max and K m are maximal velocity and Michaelis-Menten constant, respectively. Each point represents average value of 1 rat. Data points (n ϭ 23) were fitted to a straight line and analyzed by linear regression. Fig. 3 . Palmitate uptake (B) and oxidation (A) in perfused rat hindquarters as a function of total palmitate concentration at rest (y ϭ 0.014x ϩ 4.6, r 2 ϭ 0.88 for palmitate uptake and y ϭ 0.001x ϩ 0.8, r 2 ϭ 0.66 for palmitate oxidation) and during electrical stimulation (y ϭ 0.028x ϩ 1.8, r 2 ϭ 0.92 for palmitate uptake and y ϭ 0.005x ϩ 0.2, r 2 ϭ 0.89 for palmitate oxidation). Data points (n ϭ 23) were fitted to a straight line and analyzed by linear regression. 4.0 Ϯ 0.6 5.5 Ϯ 0.9* Lactate release, µmol · g Ϫ1 ·h Ϫ1 4.6 Ϯ 0.8 4.9 Ϯ 1.2
Values are means Ϯ SE of 8 observations/group. Unilateral perfusions of resting rat hindquarters were done for 20 min at 9 ml/min, followed by 20 min at 15 ml/min. * P Ͻ 0.05 compared with 9 ml/min at rest.
Because of the corresponding decrease in the fractional uptake of palmitate, the total rate of uptake of palmitate was not changed by the increase in perfusate flow rate (P Ͼ 0.05). Similarly, the percentage and total amount of palmitate oxidized were not affected by the increase in perfusate flow rate (P Ͼ 0.05). Glucose uptake was 38% higher (P Ͻ 0.05) at the higher flow rate, whereas both lactate release and oxygen uptake remained unchanged by the increase in perfusate flow rate.
DISCUSSION
Our results show that in intact perfused skeletal muscle the rates of uptake and oxidation of palmitate display saturation kinetics when plotted against the unbound perfusate plasma palmitate concentration and that muscle contractions increase the V max of the uptake and oxidation of palmitate, whereas the K m value remains unchanged. These results are consistent with the notion that the uptake of long-chain FFA across the plasma membranes of cells with high FFA fluxes is mediated in part by a saturable membraneassociated transport mechanism (3, 15, 19) . These results further suggest that the increase in the rate of FFA uptake induced by muscle contractions may be modulated in part by changes in the transport of FFA across the plasma membranes.
In isolated cell systems, the uptake of long-chain fatty acids has been shown to exhibit many of the kinetic properties of a facilitated transport process (2, 3, 21, 22, 24) . Thus the initial uptake rate of long-chain fatty acids into these cells is rapid, saturable, and reduced by prior protease treatment of the cells (2, 3, 24) . Although several proteins have been proposed as candidate long-chain fatty acid transporters (1, 8, 9, 15, 19) , the plasma membrane fatty acid-binding protein (FABP PM ), first isolated from liver tissue, has been well characterized and has been shown to exist in all cell types studied to date (21, 22, 24) . FABP PM has a molecular mass between 40 and 43 kDa, possesses a high affinity for long-chain FFA, and is structurally and immunologically distinct from the 12-to 14-kDa cytoplasmic fatty acid-binding proteins described in many tissues (15) . In each cell type studied to date, antibodies raised against the rat hepatic FABP PM selectively inhibit both FFA binding to plasma membranes and cellular flux of FFA in a dose-dependent fashion (21, 22, 24) , suggesting that FABP PM may constitute a functional FFA transporter and be part of the structural basis behind the apparent saturation type of kinetics for FFA uptake. Other proteins have been proposed as possible candidates for the transporter in adipocytes (1, 8, 9, 19) . The fatty acid translocase (FAT) was first identified in rat adipocytes by labeling plasma membrane proteins with nonpermeable sulfo-N-succinimidyl derivatives of fatty acids and measuring the initial rate of FFA uptake (8, 9) . By using an expression cloning strategy and a cDNA library from 3T3-L1 adipocytes, another plasma membrane-associated protein was independently identified and called the fatty acid transport protein, FATP (19) . The expression of this protein in cultured cells was found to be related to the rate of long-chain fatty acid transport (19) . Skeletal muscle has been shown to express both the FATP and FAT protein (19, 30) . Thus it would appear that a family of fatty acid transporters may exist.
With the physiological system used in these studies, it is not known where in the steps from the dissociation of palmitate from albumin to cellular oxidative metabolism the saturation occurs. It may be argued that the saturating effect observed in our experiments reflects saturation of an intracellular metabolic step rather than plasma membrane transport, which, in other words, indicates that metabolism rather than plasma membrane transport of FFA is rate limiting for FFA utilization. An alternative explanation might be that sarcolemmal transport is rate limiting for FFA utilization. In resting dog muscle it has recently been shown that the intracellular concentration of FFA is extremely low and that a steep gradient exists between blood and the intracellular space (29) . This finding supports the notion that sarcolemmal transport is rate limiting for FFA utilization. If so, it follows that FFA utilization can only increase during muscle contractions if FFA transport is increased compared with rest. More definitive studies using antibodies against the different putative FFA transporters and sarcolemmal membrane preparations that can more directly measure FFA transport rates are needed to answer the question of whether sarcolemmal FFA transport capacity is increased with muscle contractions and, if so, by what mechanism.
Because perfusate plasma palmitate concentration was maintained at a constant level from rest to electrical stimulation, the increase in perfusion flow rate with electrical stimulation was accompanied by an increase in the delivery of plasma palmitate to the rat hindquarter. To ensure that the measured contraction-induced increase in palmitate uptake was not due to the increases in perfusate plasma flow and plasma delivery, we perfused resting hindquarters at a rate of 15 ml/min, the same rate used for the electrical stimulation protocol. In agreement with earlier observations (26) , the uptake and oxidation of palmitate in resting perfused skeletal muscle were not affected by the increase in perfusate flow rate. Thus the contractioninduced increase in palmitate uptake was not due to an increase in plasma palmitate delivery. In contrast to palmitate and in agreement with previous results (12, 20) , glucose uptake was found to be dependent on glucose delivery. With this muscle preparation, the increase in glucose uptake that was attributable to the increase in perfusate flow rate was calculated to be ϳ24%, a value that is close to the 30% estimate calculated previously (12) .
There has been some controversy regarding the use of the FFA-albumin association constants determined by Spector et al. (23) . Indeed, it has been suggested that the association constants may be too low, resulting in calculated unbound FFA concentrations that are correspondingly high (17) . We estimated the unbound FFA concentration by using the association constants provided by both Richieri et al. (16) and Spector et al. (23) and compared the resulting calculated V max and K m values. Although the absolute values of these estimates were slightly different, the shape of the curves relating unbound palmitate concentration to palmitate uptake and oxidation and the contraction-induced changes in these estimates were similar. Accordingly, whereas the quantitative estimates may be different, this does not affect the more important qualitative assessment of the effects of muscle contractions on FFA uptake and oxidation.
In summary, the present study has shown that, when plotted against the unbound plasma palmitate concentration, palmitate uptake and oxidation by resting and contracting perfused skeletal muscle display saturation kinetics. Muscle contractions, but not an increase in plasma FFA delivery, increase palmitate uptake and oxidation by an increase in V max without changing the K m value. These results are consistent with the traditional theory of cellular uptake for protein-bound ligand and with the hypothesis that palmitate uptake across the plasma membranes of cells with high FFA fluxes is mediated in part by a transport system.
